Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial
- PMID: 22183840
- PMCID: PMC3244838
- DOI: 10.1097/OLQ.0b013e31823b50c6
Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial
Abstract
In a randomized trial among African women with recurrent genital herpes, episodic acyclovir therapy resulted in modestly greater likelihood of lesion healing (hazard ratio [HR] = 1.48, P = 0.098; mean, 5.1 vs. 6.0 days) and cessation of herpes simplex virus shedding (HR = 1.88, P = 0.008; mean, 3.0 vs. 5.0 days) compared with placebo, similar to results of studies in high-income countries (ClinicalTrials.gov registration NCT00808405).
Conflict of interest statement
Conflict of Interest:
LC has received consulting fees from AiCuris, which is developing treatments for HSV and cytomegalovirus infections, is listed as a coinventor on several patents describing antigens and epitopes to which T-cell responses to HSV-2 are directed (these proteins have the potential to be used in candidate vaccines against HSV), and has received fees for serving as the head of the scientific advisory board of Immune Design, including equity shares that are less than 1% ownership. AW has received consulting fees from AiCuris. AW and CC have received research grant support from GlaxoSmithKline. All other authors declare they have no known conflict of interest.
Figures


Comment in
-
Utility of episodic acyclovir therapy for HSV-2 in Africa.Sex Transm Dis. 2012 Jan;39(1):25-7. doi: 10.1097/OLQ.0b013e31823fadf3. Sex Transm Dis. 2012. PMID: 22183841 No abstract available.
Similar articles
-
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.J Infect Dis. 2009 Oct 1;200(7):1039-49. doi: 10.1086/605647. J Infect Dis. 2009. PMID: 19715417 Clinical Trial.
-
Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991. J Infect Dis. 2009. PMID: 19530940 Clinical Trial.
-
Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.Sex Transm Dis. 2011 Sep;38(9):865-70. doi: 10.1097/OLQ.0b013e31821d4ceb. Sex Transm Dis. 2011. PMID: 21844743 Clinical Trial.
-
Current recommendations for the treatment of genital herpes.Drugs. 2000 Dec;60(6):1329-52. doi: 10.2165/00003495-200060060-00007. Drugs. 2000. PMID: 11152015 Review.
-
Herpes. Atypical clinical manifestations.Dermatol Clin. 1998 Oct;16(4):783-8, xiii. doi: 10.1016/s0733-8635(05)70047-4. Dermatol Clin. 1998. PMID: 9891681 Review.
Cited by
-
20 years of herpes simplex virus type 2 (HSV-2) research in low-income and middle-income countries: systematic evaluation of progress made in addressing WHO priorities for research in HSV-2/HIV interactions, HSV-2 control and mathematical modelling.BMJ Glob Health. 2024 Jul 4;9(7):e015167. doi: 10.1136/bmjgh-2024-015167. BMJ Glob Health. 2024. PMID: 38964882 Free PMC article.
-
High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.PLoS One. 2015 Mar 17;10(3):e0119886. doi: 10.1371/journal.pone.0119886. eCollection 2015. PLoS One. 2015. PMID: 25781986 Free PMC article.
-
Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.Curr HIV Res. 2012 Apr;10(3):228-37. doi: 10.2174/157016212800618156. Curr HIV Res. 2012. PMID: 22384842 Free PMC article. Review.
-
Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women.Sex Transm Infect. 2015 Nov;91(7):485-8. doi: 10.1136/sextrans-2014-051867. Epub 2015 Apr 22. Sex Transm Infect. 2015. PMID: 25904747 Free PMC article. Clinical Trial.
References
-
- Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83. - PubMed
-
- Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis. 2004;190:1374–81. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical